The acute inflammatory response to sepsis gives rise to significant morbidity and mortality. The mechanisms underlying this form of tissue injury are poorly understood. This review examines the evidence that tissue ischaemia due, to generalized microvascular thrombosis may play an important role.
Recent studies in sepsis demonstrate that the body's acute inflammatory response is an important factor in the development of organ failure. The administration of endogenous inflammatory mediators, such as tumour necrosis factor (TNF-α) or interleukin-1 (IL-1), reproduce many of the clinical features of sepsis 1, 2 . Conversely, antagonists of these mediators reduce organ failure and mortality in animal models of sepsis [3] [4] [5] .
Currently the mechanisms by which the acute inflammatory response causes tissue injury remain poorly understood. Consequently few interventions exist to prevent or treat it. This is a major problem, as the personal and economic costs of this form of tissue injury are substantial. In Australia and New Zealand the incidence of severe sepsis is 0.77 per 1000 population. This figure indicates that around 13,500 patients develop this condition each year 6 . Mortality is substantial and 32% of patients will die within 28 days of diagnosis 6 .
There is much debate regarding the mechanisms by which the acute inflammatory response causes tissue injury. Proposed mechanisms include (a) cellular membrane damage due to reactive oxygen species released by leucocytes, such as peroxynitrite 7 , (b) degradation of the sub-endothelial basal lamina of the microvasculature by proteolytic enzymes released by leucocytes 7 , (c) apoptosis of the immune system 8 , (d) impaired metabolism due to mitochondrial dysfunction 9 , and (e) tissue ischaemia due to microvascular obstruction [10] [11] [12] . A number of mechanisms of microvascular obstruction have been proposed. These include vasoconstriction 13 , leucocyte margination and aggregation 10 , endothelial swelling, reduced red blood cell compliance 14 , and thrombosis 11, 12 .
Of the potential mechanisms underlying tissue injury associated with the acute inflammatory response, a substantial body of evidence indicates a role for microvascular obstruction due to thrombosis. Inflammation and thrombosis are intimately linked 15 . Inflammation up-regulates pro-coagulant factors, such as tissue factor (TF), platelet reactivity and fibrinogen levels. It down-regulates natural anticoagulants, such as protein C, protein S, thrombomodulin, and antithrombin, and it also inhibits fibrinolytic activity through increased expression of plasminogen activator inhibitor (PAI)-1. A number of clinical examples illustrate this association between inflammation and thrombosis [15] [16] [17] . In patients with atherosclerotic disease increased levels of C-reactive protein are associated with an increased risk of cardiovascular events due to thrombosis 17, 18 . Acute transplant rejection results in thrombosis of the transplanted organ 19, 20 , and inflammation associated with sepsis triggers disseminated intravascular coagulation (DIC) 16, 21 .
An Overview of Coagulation
The expression of membrane bound TF in association with the blood-borne coagulation factors triggers coagulation activation and fibrin formation ( Figure  1 ). TF binds to the small fraction of factor VII that circulates in the active form. This complex converts factors IX and X to their active forms, which in turn amplify further activation of factor VII. Factor Xa and its cofactor V convert prothrombin to thrombin and consequently fibrinogen to fibrin. Factor VIII is activated by thrombin and further amplifies Xa production on the platelet surface in conjunction with IXa 22 . This mechanism of coagulation activation is known as the extrinsic pathway. The intrinsic pathway (an alternate mechanism) is not thought to play a significant role in vivo [22] [23] [24] .
Coagulation activation is regulated by a number of additional factors. Tissue factor pathway inhibitor (TFPI) is released from activated endothelial cells and inhibits the TF/VIIa complex. Antithrombin inhibits free rather than membrane-bound coagulation factors including thrombin and Xa 24 . Antithrombin's action is enhanced by heparin. Thrombin also binds with membrane-bound thrombomodulin and protein S to activate protein C, which in turn inhibits factors Va and VIIIa. Fibrin deposited in the intravascular space is usually rapidly removed by the action of tissue plasminogen activator (t-PA), which is released by activated endothelial cells ( Figure 1 ). t-PA converts circulating plasminogen to plasmin which in turn lyses fibrin and gives rise to fibrin degradation products, such as D-dimer. This endogenous process of fibrinolysis is regulated by PAI-1, which inactivates t-PA and therefore inhibits fibrinolysis.
Changes in Coagulation Associated with Sepsis
The administration of endotoxin to human volunteers triggers coagulation activation. Markers of coagulation activation including thrombin-antithrombin and prothrombin factor 1+2 (PTF) increase from 2 hours following the septic insult and peak at around 6 hours 23, 25 . These changes are associated with a simultaneous increase in PAI-1 levels indicating inhibition of fibrinolysis 23, 25 . The recombinant human activated protein C worldwide evaluation in severe sepsis (PROWESS) trial also demonstrated a prothrombotic response in patients with sepsis. This trial enrolled 1690 patients with severe sepsis. At baseline almost all patients had elevated PTF, thrombinantithrombin and D-dimer levels. PAI-1 levels were also raised in about half the patients. In addition, reduced levels of inhibitors of coagulation were found: 89% of patients had reduced protein C levels, 78% reduced protein S levels and 82% reduced antithrombin levels 26, 27 .
Microvascular Changes Associated with the Acute Inflammatory Response

Inflammatory mediators
The presence of bacteria in the tissues triggers the production of inflammatory mediators ( Figure 2 ). Tissue macrophages produce TNF-α and IL-1 28, 29 . The complement cascade generates C5a, C3a and C5b-9 30 and the contact cascade generates bradykinin 31 . At a local level these inflammatory mediators drain from the capillary bed and activate specialized endothelial cells lining the post-capil-lary venule (PCV) 32, 33 . Activation of these cells results in a series of fundamental changes that give rise to the local clinical manifestations of the acute inflammatory response and potentially microvascular thrombosis. If these inflammatory mediators reach the circulation in sufficient concentrations they may also trigger the systemic features of inflammation including fever, tachycardia and neutrophilia 34, 35 .
Leucocytes
Within minutes of activation, the endothelial cells lining the PCV express pre-formed P-selectin and von Willebrand Factor (v-WF) on their luminal surface [36] [37] [38] . P-selectin mediates margination of circulating monocytes and polymorphonuclear (PMN) cells, while v-WF mediates adhesion of circulating platelets [36] [37] [38] . Some hours later the endothelial cells of the PCV also express intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 39, 40 . These endothelial receptors mediate firm adhesion of monocytes and PMN cells, they promote the formation of leucocyte aggregates and also play an important role in the migration of monocytes and PMN cells into the extravascular space ( Figure 3 
Vasoconstriction
In animal studies the injection of inflammatory mediators or endotoxin reduces microvascular blood flow through vasoconstriction of both arterioles and venules 32, 41 . Reduced microvascular blood flow due to vasoconstriction has also been demonstrated in human sepsis 13 .
Thrombosis
Activation of endothelial cells and the adherent monocytes lining the PCV by inflammatory mediators also triggers these cells to express TF and PAI-1 10,42-44 . TF activates blood-borne coagulation factors resulting in fibrin deposition within the PCV, while PAI-1 inhibits t-PA and thereby prevents fibrin removal ( Figure 4) 24, 45, 46 . This combination of microvascular leucocyte margination and aggregation, vasoconstriction and expression of TF and PAI-1 may ultimately result in complete microvascular obstruction due to microvascular thrombosis ( Figure 5 ) 10, 11 .
Microvascular Thrombosis Associated with Bacterial Infection May Have an Adaptive Role
Histological examination of infected tissues reveals a central zone comprising bacteria and necrotic tissues. A ring of thrombosed vessels surrounds this central zone, which in turn is surrounded by a ring of macrophages and PMN cells 47 . Over a period of days the macrophages and PMN cells infiltrate the central zone, eliminate the bacteria and repair the damaged tissues 48, 49 . These findings suggest that microvascular thrombosis may provide a rapid mechanism to block the microcirculation and thereby prevent bacteria accessing the systemic circulation. In time a definitive response is mounted by leucocytes that infiltrate the infected tissues, remove the pathogens and repair the damaged tissues. This response may cause the cells in the central infected zone, supplied by the surrounding thrombosed capillary beds, to die. This may however be a small price to pay if their sacrifice prevents bacteria reaching the systemic circulation.
Other studies also suggest that microvascular thrombosis may have a role in limiting the systemic spread of bacteria. The capacity of pathogenic bacteria to trigger fibrinolysis in the host was shown to be an important factor in their ability to spread throughout the body. Pathogenic bacteria including 
Escherichia coli, Staphylococcus aureus, Streptococcus species, Neisseria meningitidis, Pseudomonas aeruginosa, Borrelia Burgdorferi, Haemophilus influenza and
Salmonella enteritidis all possess intrinsic mechanisms that dissolve fibrin. These bacteria express receptors that bind human plasminogen and trigger its conversion to plasmin 50 . The importance of this mechanism to their systemic spread was demonstrated in an animal model deficient in plasminogen. Using this model, researchers found that the systemic spread of Borriella burgdorferi was markedly reduced compared with plasminogen sufficient animals 51 .
Other pathogenic bacteria including Yersinia pestis, Group A streptococci and Staphylococcus aureus are also capable of removing fibrin through expression of plasminogen activators including streptokinase and staphylokinase. In a study of a mutant strain of Yersinia pestis deficient in plasminogen activator, the systemic spread of the bacterium was markedly reduced, and the LD 50 was increased one millionfold 52 .
Microvascular Thrombosis Can Cause Tissue Ischaemia
While microvascular thrombosis associated with the acute inflammatory response may have a beneficial role, it may also cause harm through tissue ischaemia. Histological examination of acutely inflamed tissues in which microvascular thrombosis was present demonstrated changes consistent with cellular hypoxia due to ischaemia 11, 12, 47, 53, 54 . Other studies also suggested acutely inflamed tissues were hypoxic. In studies undertaken on rats, an inflammatory response was generated by the insertion of a hollow cellulose sponge into the subcutaneous tissues. Inflammatory fluid was allowed to accumulate in the hollow of the sponge and the partial pressure of oxygen (PO 2 ) in the fluid analysed. Over the first 5 days the PO 2 of the inflammatory fluid dropped from 140 to 9 mmHg. These changes gradually resolved over the next 25 days 55 . Subcutaneous inoculation of bacteria gave rise to similar results 56 . Examination of the peritoneal fluid of both humans and animals with abdominal bacterial infections also demonstrated reduced PO 2 levels and increased lactate levels [57] [58] [59] [60] .
A number of other aspects of the acute inflammatory response also indicated that acutely inflamed tissues were hypoxic. Macrophages are a fundamental component of this response. These cells enter acutely inflamed tissues, eliminate bacteria, and subsequently coordinate repair of the damaged tissues. These cells possess specialized metabolic pathways that allow them to survive in hypoxic environments for pro-longed periods. Furthermore, in response to hypoxia these cells express TF, PAI-1, TNFα, interleukin 6 (IL-6), fibroblast growth factors and angiogenesis factors [61] [62] [63] [64] [65] [66] [67] [68] . These factors attract fibroblasts and angioblasts to the acutely inflamed tissues. Fibroblasts convert the fibrin provisional matrix to fibrous tissue, and angioblasts mediate neo-vascularization which restores the microcirculation to the inflamed tissues 49 . If macrophages are unsuccessful in eliminating the bacteria, neo-vascularization does not proceed and an avascular abscess or granuloma forms, surrounded by a fibrous capsule 48, 54, 56 . These characteristics of the acute inflammatory response add further weight to an association between acute inflammation and the development of tissue ischaemia.
Generalized Microvascular Thrombosis May Contribute to Organ Failure and Death
The sacrifice of the cells supplied by a few capillary beds is clearly a small price to pay if this prevents the systemic spread of bacteria. On the other hand, if microvascular thrombosis were generalized, then extensive tissue ischaemia could precipitate organ failure and death. The following sections present evidence that generalized microvascular thrombosis, associated with the acute inflammatory response, may contribute to organ failure and death.
Histological Evidence
Yoshikawa et al 21 , in a comprehensive review of the autopsy findings in septic patients with DIC, found the extent of necrotic tissue injury was dependent upon both the quantity and the duration of thrombosis. They found many organs were involved, but the kidney, liver, lung, gastrointestinal tract, adrenal glands and brain were most severely affected. Powell 69 , in a series of 40 fatal cases of staphyloccocal septicaemia, found renal thrombi present in 75% of cases. The glomerular and inter-lobular capillaries were most frequently involved and were associated with tissue lesions, which appeared ischaemic in nature. In the lungs, thrombi in the small calibre vessels were associated with necrosis of the adjacent vascular wall. Similar lesions were found in the liver, spleen, brain, and adrenal glands. Both Margaretten 70 and Kojima et al 71 also demonstrated a clear correlation between thrombi and ischaemic tissue damage. These authors documented thrombi in glomerular capillaries and the inter-lobular arteries of autopsy cases. This distribution corresponded with the vascular supply of the infarcted renal cortex, while the medulla and pelvis were spared because they received an independent blood supply from the arcuate arteries.
Contrary results were reported by McHenry et al 72 who studied the autopsy findings of 33 cases of Gramnegative bacteraemia. While there was evidence of focal tissue injury in the lungs, gut, spleen, adrenal, and kidney, in most of the cases there was however no evidence of microvascular thrombi. These findings may reflect the dynamic balance between fibrin generation and fibrinolysis. Histological studies in both animals and humans demonstrate a peak in microvascular thrombi at 3 to 24 hours after the inflammatory insult. Thereafter, microvascular thrombi were rarely found, presumably due to fibrinolysis or fibrin removal by leucocytes [73] [74] [75] [76] [77] . Histological samples taken 24 hours after the inflammatory insult may therefore demonstrate tissue necrosis due to infarction, but without evidence of microvascular thrombosis.
The Acute Respiratory Distress Syndrome and Microvascular Thrombosis
Microvascular thrombosis was also shown to be associated with lung injury in the acute respiratory distress syndrome (ARDS) [78] [79] [80] . One study found the onset of pulmonary microvascular thrombi was temporally associated with the clinical onset of ARDS 76 . Other studies found an association between the extent of microvascular obstruction on pulmonary angiography and both the severity of respiratory failure and mortality 81, 82 .
Studies of Coagulation Activation and Fibrinolysis
The acute inflammatory response triggers coagulation activation and inhibition of fibrinolysis within the microcirculation. Consequently, if generalized microvascular thrombosis were a mechanism of tissue injury, then systemic markers of coagulation activation and inhibition of fibrinolysis might be expected to be associated with measures of tissue injury.
In patients presenting with septic shock, mortality correlated with markers of coagulation activation, including PTF and fibrin degradation product levels 83 . Mortality also correlated with markers of increased inhibition of fibrinolysis, including PAI-1 and PAI activity levels [84] [85] [86] [87] [88] . Mortality was also correlated with lower levels of inhibitors of coagulation activation including antithrombin and protein C levels 83, 84, 89 .
Studies of Interventions to Inhibit Coagulation or Promote Fibrinolysis in Sepsis
A number of experimental therapies in sepsis, which include the administration of inhibitors of coagulation activation and thrombolytic agents also suggest microvascular thrombosis may play a role in tissue injury.
Inhibition of coagulation activation
In baboon models of septic shock the prophylactic/early administration of inhibitors of coagulation activation, such as Hirudin TF inhibitor, VIIa inhibitor, Xa inhibitor, antithrombin, TFPI and protein C were all associated with reductions in morbidity and mortality [90] [91] [92] [93] [94] [95] . Futhermore, in two studies reduced organ dysfunction was associated with histological evidence of reduced microvascular thrombosis in the kidneys and to some extent in the lungs 96, 97 .
A number of anticoagulant therapies have now been assessed in phase III trials of patients presenting with sepsis associated with one or more organ failures. The results of these trials have been mixed. In a trial which enrolled 2314 patients, treatment with high-dose antithrombin was not associated with a reduction in 28 day mortality 98 . A trial of TFPI which enrolled 1754 patients was also not associated with a reduction in 28 day mortality 99 . The PROWESS trial, which was referred to earlier in this review, did however demonstrate a significant 19% relative reduction in mortality associated with activated protein C (APC) administration 27 .
It is interesting that in each of these trials, an interaction between the use of prophylactic doses of heparin ( 10,000U per day) and the study drug was found. Heparin has both anticoagulant and antiinflammatory effects like the trial drugs 100 . In both the antithrombin and TFPI studies sub-group analysis of patients that did not receive heparin (around 30% of the enrolled patients) demonstrated a benefit with the study drug (Table 1 ). In the antithrombin trial 28 day mortality was reduced from 44 to 38% (P=0.10) and 90 day mortality was reduced from 53 to 45% (P=0.03). In the TFPI trial 28 day mortality fell from 43 to 35% (P=0.05). Simarlarly, the major benefit of APC was found in patients that did not receive heparin. In this group 28 day mortality fell from 39 to 24% (P=0.001). While in those that received heparin (68% of the trial population) there was no significant difference in mortality between placebo and treatment arms 28 to 25% (P=0.2) 26, 101 . Additionally, if the data from the placebo arms of these three studies are pooled, and a comparison is made of patients that received heparin to those that did not, heparin use was associated with an overall reduction in 28 day mortality from 42 to 32% (P<0.0001). A similar analysis involving only the antithrombin and APC trials has been previously presented 101 .
These findings suggest that the failure of the antithrombin and TFPI studies to demonstrate an overall drop in 28 day mortality reflected the administration of heparin to around 70% of the placebo patients. Heparin may have reduced overall mortality in the placebo groups which limited any potential efficacy of the trial drugs from being demonstrated. It is however, important to be cautious with this interpretation as it is based on sub-group analyses which may be affected by a range of confounding variables.
Fibrinolysis
Hardaway et al 102 , using a pig model of septic shock, demonstrated that the early administration of the plasminogen activator urokinase was associated with a significant reduction in mortality. Similar benefits of early fibrinolysis were also demonstrated in both rabbit and rat models of sepsis 103, 104 .
A number of non-randomized trials of fibrinolytic agents were undertaken in critically ill patients with ARDS. One trial suggested that survival was improved with the administration of fibrinolytics compared with historical controls 105 . Another study found a temporal association between fibrinolysis and improvements in the P a O 2 106, 107 . Other trials found fibrinolysis was associated with clearance of filling defects on pulmonary angiography and improved pulmonary haemodynamics 108, 109 . In a randomized blinded trial urokinase activated plasmin was administered as a single intravenous dose and as an aerosol to premature infants with acute lung injury due to hyaline membrane disease. This intervention reduced the death rate from 61 to 28% 110 . The results of this study may however be questioned due to the high dropout rate and therefore significant loss to follow up (25%).
In conclusion, microvascular thrombosis may be an important mechanism by which the acute inflammatory response limits the systemic spread of bacteria. However, if microvascular thrombosis becomes generalized it may cause extensive tissue ischaemia and contribute to organ failure and death. The findings of this review support further studies to establish the role of microvascular thrombosis. Such studies may hopefully lead to new therapies to limit or prevent this form of tissue injury. CI denotes confidence interval, APC activated protein C, AT antithrombin, TFPI tissue factor pathway inhibitor.
